Attached.

PRIMO eHEMiCALS PCL:SEC:2026:284 28th September, 2026 B PM SS J cu TE rm ioL pbwi cam e oi -ri d st 4e e, 0Dd :0 5a0 0la0 6I1 8S 5t 2reet NE BM Sx aa yuc nt mmiho dba bn raana o Kigl l– :eS u P rP 4t lo Ra0lca I0C Mkz 0 a o O5, mE 1Cx ,p c– Mleh xaa1 ,hn, aB Bg rel aao no sc df hk r tI- arn a G (d ,E Ii, na ),d L iaimited S(RLu eisb vti.is:n eOgd uOtcbolmigea toiof ntshe a nBdo Darisd cMloeseutirnegR ehqeludi roenm 2e5ntht Ss}Re peteqmublaetri,o n2s0,22 06,1 p5u €trhseu a“nSt EtoB It hLeO SDERB”II- Ref: BSEQ uery via email dated 2681 September, 2026, Dear Sir/Madam, This is with reference to the query received from the BSE dated 26tt1 September1 2026, seeking abthdya dttht it heio e nC saoalm d idep t aaa nnils ny oaousnn p2cee5mrth S e SE neB tp sIt ehCmoir ubc ledur la,b 2r e 0d r2a e6t ae ddva i 3ds0e t l uhe n Jt dtae en rr : unaory. ,P 2C0L2:6S fEorC :t2he0 A26n:n2o8u3n, cweem weinsht stou bsmubittmeidt Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and D tDch oiei rms erc ecml uto oenrs ndsu ce oer re fd Ra P n are imd tq o 1ou t 3ih Cr :ee 3hmr 0e a m Hep in ocpt aulsi lc rs) s R a L abe imnlge idu t pe l r cda o oat vi tnio s ictn iso ls unm,2 s d e,0 e i ef1 d ti5 a an n tg ( y 1“ hS, 5 ew :E 0lde 0B t ow HI dLi oasO uyh ,rD st i.oR ,e i.” ni n) Ft f eri on idrrc m aal ylu iY ,a2 do ,5i n hu thg a t S shc e ia cr poct t t neuh smlea idb r eBes rro e,i sa2dsr0 du a2 e no6 ddf, approved the following matters: 1.D(“Fraloftw S cTheemche” /o f “ATrmaanlsgfaemroar tiCono( m“Spcahneym”)e w”) iothf FPlorwim Toe cChh Cehmeimcaiclsa lsL iPmriivteadte L(“iPmCitLe”d/ “Transferee Company”)a nd their respective shareholders and creditors. D“Trraafnt Ssfcehroerm (e', oomf Apmanaylg”)a, ma atwiohno (l“lyS cohwenmeed” ) soufb Fsliodwia Trye cohf CPhreimmoic Calhse Pmriivcaatlse LLimimitietedd ,( “Fwloitwh TPercimh”o/ Cuoonffh tAde hseem sr tToiac crakaiil anns t g;iL fo(ei nsm io) 1i Fat pe n Crd doo A pm(“ reP tpr i( cta.i, leL ens” sy/1 “bpo Tuuf rsra Asinnusse safs ones ctr ,te i oaea tSi s oC es neco ottm is fo ,p n l ti ha a2enb3 yi Tl0”it r) -i a, e t 2nos3s, 2fm er, iereg onrh rg a tes Cb, lt o ihbnmeeg pn e paen ronftiitvyrse i s, a oionbbndul Tis sg ri oan afte n itohs sns efe s a Mr enaeednm dt Coh i ore namt ew nr pdeh asuo t nmsle y av pn ead rr mi oa isull sso io tch noe snr d oaift p tiohpnelis c m1a ebi mlne bcp elruo rsdv ,ii sn ci rog en s dsu it obo rjf se t ,h ce at ntoC d o o tmn he ep rca en ci lse ass sAa secryt s, a op2 f 0p p1 ero3 rs,v oifa nla ssn ,/ c i y f o, s an nus Ybe ,j e snc att ns ct/o ts i osaa nnt bics Yftai Nocn Ctios Ln aT n o odf r sausc mh aoyth beer creoqmupireetde( ncto alleucthtiovreitlyy , aresf emrraeyd btoe a asp “pRliecgaubllaet aonryd A ouththeor ristiteastu”)t oarnYd/ r esugcuhla otothrYer a uatphporroitvieasl?l /s t huc ebo j Rnes ecet g tn uot l s a/s t ous rca yhn A cc utoi ton hnd osi rt ii to/ i p ene ss ,r a mn wids hs imi lo eon gds ri f a/i c nea tx it nieo gmn ssp u at cios h n ms a,a p ay p s rb o me va ap ly sr eb /se c c rr oeib nqe sud eiro ner td s i mu / snp ado nes cre t id oa npb spY l it /ch a peb e Nl re mC la iL swT ss i o o r na n sbd Y/ exempions. T'he Appointed Date for the Scheme of Amalgamation shall be 1 ;t October, 2026. T Rh eqe u direetmaielsn ta s)s Rre egq uu lair te iod n u stn 2d 0e 1r 5 R reeagdu lawtiitohn S 3 E0 B I o Mf aS stE er B CI ir(cLuislatinr ngo O . Sb Eli Bg Ia / t Hio On /s 4a 9n /1d 4 /D1i4s(c7lo)2s0u2re5s- CFD-POD2/1/3762/2026 dated 30th January, 2026 are provided in Annexure I. PRIMO CHEMICALS LIMITED PHONE :0 172-2801649.6R50E. G WIS OETMRE KAR SIL E ::D &INN A CFNOO G@R APLPR-UOIMNR AOA CTHREEOOM AFIDCF .A I NLC ASE Y.I: AN B A NY ACNN INGO:A. 4LL2-6 14- 415 010 192.C 6SH E1DC9IST7H5OP. RLC3 R tOO .A0P3A. 6RC0,7 H PA UWN NED JBAISBGI.T AEIR N H:D WI- A1W6W0.0P3R0IMOCHEMICALS.IN You are requested to please take note of the same. Thanking You, For Primo Chemicals Limited SCuogmanpdahnay SKeuckreretajary & Chief HR Officer Annexure I D m=e Mt sa Hil Xs Mm o Our mDsu Ra ”)n B,t to Z R ]eg aula Xtion 2 30 m of rSE 8BI (L yist ming r eO ab dl w ig ia thti o Sn Es B a In Md a sD teis rc Clo irs cu ur le as r Nf ado mear tm aam ligli sen a g min o a f bti orp nit e/ah mfre st e urgcee ho rn , f at it sy( sie it zsh e)e ,r T “T e rac nh sf eC roh r”e ),m ai wca hl os ll yP or wi nv ea dt e s uL bi s [m Aid mi it a oen r uys d nof e tf( r i“e ntF he e R” lo) C sa w o .n m L d T ape F kacl ho nh sw Y”/. turnover etc. L 31a.0s 3o.2n0 2611 31.03o.n2026 Primo Chemicals 1 LFilmowite Tdech Chemicals 34,166.14 2,019.27 Whether the transactionCPhreivmatiec aLilms ited Private Limited (“Flow Tech”/ would fall within related “Transferor”) is a wholly owned subsidiary of the PCL. The p wa hr et ty etr ra thn es a sc at mio en is s? dif ny ee as t, ptrraonpsoascetido mn. erger falls within the purview of related partY “arm’s length. However1t he proposed merger will not fall within purview of related party transactioni n terms of section 188 of A enr tie tya (ie o s)f business of the C P Lo ir mm imp ita o en dCie hs eA mct i, c 2 a0 ls13. P mC anL u fai cs tu rine gn goaf gCeadu sitIiIc Sotdhae LCyhel,o Crainuest,i c HSyoddrao Fclhalkoersic, LAiqcuidid, SGoadsi,u mS HByPp ocahnlodr ite A,H luymdriongiuemn CPchCh llLoo ir rsi id nce ea.T u, hsteich ymsdaoridona cp lhyroelod au rinc ctd o lif aq ctu ih dide , Flow h hvy od or co Thg leoe rcn ithe g aisra es ie tsn ga byan egd -ep rdos ido nud ciu tthsm.e Chemicals I manufacturing of Chlorinated R mea rt gio en rale for amalgamation/HfoP7lbr loi=v wa©it n;eag a L bmi emTnigeteafid trsn :atioIn P araffin aisn edx Hpeycdtreodc htloo ripc rAocviidd.e the a. Lcereaaditniogn t oo f a ma ocreo nesffiocliiednat teutdibl izaastieo no fo f acsaspeitatsl aanndd rsehsaoruerhcoelds erfos ra funtdu arel l gortohwetrh s taankde hao lgdreerast;er value for bSinitmegprliafitcinagti F o -n loo wf Toevcehr'asl lo gpreoruapti sotnrusc d t iru er ce tl b y y w fituhlIinY Primo and creating efficiencies via amalgamation; c. Reduction in the managemento verlaps due to olepaedreartsiohnip o;f the multiple entities and more focused d. Reduction in multiplicityo f legal and regulatory cadomminpilsiatrnatcivees, ,rm eadnuacgteiorinal inan do votehrehre caodssts,i nacmluodninggst all; e.Scoynnseorglidy abtieonneo ffi tbsu, ssiuncehs saess toco mcopmebtiintiev eg reodwgteh, owphpiocrhtu wnoitiuelsd t oin c-atupritna liszieg noifnic fauntutlrye hgerolpw tihn peoftfeicnietinatl utilization of financial and operational resources;a nd f. P fino ao nl cin iag l, o mf a nap gro erp iari l e at na dry i on thfo er rm rea st oio un rc, e pse, rtshoenrenbeyl, In case of cash considerationNot cAopnptrliibcuatbinlge t,os fuitnurec gmrowteh a em xco hu an nt g o er r ao tt ioherwise share pa S Paa nr c Cey dh Lm n e .p o m Aer o ccn ep oct , o oo naf rs s s de ia d idF nn e gly rot al o ywc t,i a oT nbs noeh e c i s c shi o h s pin as s as r u yei aade e be wd xlr e h cab ho tt oiy alo l y tnn hP g ea oC e s w s L hn r anp ae to ru d ieo re h ssq iou suu l b da ait s ey pn i rd pt ss it la h io ocra fa y rt t bh he o le es ef B shr aie ref hd oe ldta inil gs p o af t tech rna (n ifg ae n yin ) TN shroa atn rAs efpe hpr ooli lcr d Ca ib nolm ge, p p asani tn tec re n th oe f re th w eil l b Te ra nn so f ec rh ea en g Ce o min p t ah ne y of listed entity pe Cshuq oar mus ru ei pta hy an o nst lyd hto ia n t grh ae e nps dap t trh to ea tp rhnto e w s oeil fdl pt hrSb eeec h Ci aes onms mdue p.e s adi npn yocb e sy wt t oht uhe ale dr me T raeisrlgma n an ao ms i nff aer e ttr hies oeeh n same